Hong Kong stock market anomaly | Sinopharm (03933.HK) rises more than 3% with Sinopharm Biotech receiving milestone payment related to exclusive licensing agreement for Novonordisk UBT251.
According to the Wise Finance APP, Federal Pharmaceutical (03933.HK) has risen over 3%, as of the time of publication, up 3.03% at HK$9.51, with a trading volume of HK$64.1872 million.
Latest
